Award notice Supplies

Rammeaftale om køb af Beyfortus (nirsevimab)

Notice published in Danish. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: Amgros I/S
København Ø
Place of performance: København Ø
Planned end of contract: 31 July 2028
likely re-tender around January 2028
Bids received: 1
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Negotiated procedure without prior publication
The buyer consulted a few companies directly: it is no longer possible to take part.
Publication: 19 August 2026
Notice language: Danish

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Beyfortus (nirsevimab). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.

Awarded to

Sanofi A/S

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Similar contracts already awarded

Contract	Winner	Amount
Amgros 2027 1.1179.a Amgros I/S · 22 October 2026	Stemline Therapeutics B.V.	–
Amgros 2027 1.355.a Amgros I/S · 22 October 2026	Pfizer ApS	–
Amgros 2027 2.214.b Amgros I/S · 22 October 2026	Teva Denmark A/S	–
Amgros 2027 1.359.a Amgros I/S · 22 October 2026	GlaxoSmithKline Pharma A/S	–
Amgros 2027 1.1207.a Amgros I/S · 22 October 2026	Vingmed A/S GE Healthcare A/S Bracco Imaging Scandinavia AB Bayer A/S	–

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 572704-2026.